Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoru Inoda

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Plos One|March 11, 2020
Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degenerationYusuke Arai, Hidenori Takahashi, Satoru Inoda, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 6, 2018
Visual acuity loss associated with excessive "dry macula" in exudative age-related macular degenerationHidenori Takahashi, Yuji Inoue, Xue Tan, et al.
International Journal of Molecular Sciences|January 25, 2025
Comparative Pharmacokinetic Analysis of Aflibercept and Brolucizumab in Human Aqueous Humor Using Nano-Surface and Molecular-Orientation Limited ProteolysisKosuke Nagaoka, Natsuka Kimura, Satoru Inoda, et al.
Translational Vision Science & Technology|February 20, 2025
Effect of Combination Use of Aqueous Humor Secretion Inhibitor Eye Drops on Aflibercept Level: A Preliminary AnalysisSatoru Inoda, Hidenori Takahashi, Ryota Takahashi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 5, 2018
Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective studyShinichi Sakamoto, Hidenori Takahashi, Yuji Inoue, et al.
Journal of Medical Case Reports|February 28, 2024
Scleritis following intravitreal brolucizumab injection: a case seriesTakuya Takayama, Satoru Inoda, Hidenori Takahashi, et al.
Sensors (Basel, Switzerland)|December 11, 2025
Intraocular Cytokine Level Prediction from Fundus Images and Optical Coherence TomographyHidenori Takahashi, Taiki Tsuge, Yusuke Kondo, et al.
International Ophthalmology|August 9, 2025
Aqueous humor cytokine profile in insufficient responder to aflibercept for neovascular age-related macular degenerationRyo Terao, Ryo Obata, Atsushi Okubo, et al.
Scientific Reports|December 30, 2025
One year outcomes of intravitreal faricimab for treatment Naïve neovascular AMD and associations with baseline aqueous humor cytokinesSatoru Inoda, Hidenori Takahashi, Yuto Hashimoto, et al.
Scientific Reports|December 17, 2022
Deep-learning-based AI for evaluating estimated nonperfusion areas requiring further examination in ultra-widefield fundus imagesSatoru Inoda, Hidenori Takahashi, Hitoshi Yamagata, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Plos One|March 11, 2020
Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degenerationYusuke Arai, Hidenori Takahashi, Satoru Inoda, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 6, 2018
Visual acuity loss associated with excessive "dry macula" in exudative age-related macular degenerationHidenori Takahashi, Yuji Inoue, Xue Tan, et al.
International Journal of Molecular Sciences|January 25, 2025
Comparative Pharmacokinetic Analysis of Aflibercept and Brolucizumab in Human Aqueous Humor Using Nano-Surface and Molecular-Orientation Limited ProteolysisKosuke Nagaoka, Natsuka Kimura, Satoru Inoda, et al.
Translational Vision Science & Technology|February 20, 2025
Effect of Combination Use of Aqueous Humor Secretion Inhibitor Eye Drops on Aflibercept Level: A Preliminary AnalysisSatoru Inoda, Hidenori Takahashi, Ryota Takahashi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 5, 2018
Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective studyShinichi Sakamoto, Hidenori Takahashi, Yuji Inoue, et al.
Journal of Medical Case Reports|February 28, 2024
Scleritis following intravitreal brolucizumab injection: a case seriesTakuya Takayama, Satoru Inoda, Hidenori Takahashi, et al.
Sensors (Basel, Switzerland)|December 11, 2025
Intraocular Cytokine Level Prediction from Fundus Images and Optical Coherence TomographyHidenori Takahashi, Taiki Tsuge, Yusuke Kondo, et al.
International Ophthalmology|August 9, 2025
Aqueous humor cytokine profile in insufficient responder to aflibercept for neovascular age-related macular degenerationRyo Terao, Ryo Obata, Atsushi Okubo, et al.
Scientific Reports|December 30, 2025
One year outcomes of intravitreal faricimab for treatment Naïve neovascular AMD and associations with baseline aqueous humor cytokinesSatoru Inoda, Hidenori Takahashi, Yuto Hashimoto, et al.
Scientific Reports|December 17, 2022
Deep-learning-based AI for evaluating estimated nonperfusion areas requiring further examination in ultra-widefield fundus imagesSatoru Inoda, Hidenori Takahashi, Hitoshi Yamagata, et al.
Pageof 5